NIH-funded research R01 grant

Investigating how metabolic changes in cells contribute to vision loss in diabetes

Official title: The Warburg Effect and Diabetic Retinopathy

Funded at Wayne State University · NIH-11089313 · Data updated 2026-11-12

This study is looking at how certain cells in the eye change their energy use to help grow new blood vessels when someone has long-term diabetes, which can cause serious vision problems, and the goal is to find new ways to treat diabetic retinopathy to help protect your sight.

More Diabetic Retinopathy research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWayne State University
NIH-funded
Lab location1 site (Detroit, United States)
Project startJune 1, 2023
Project endMay 31, 2028
Funding year2025
Award (this year)$385,000
NIH project number5R01EY034964-03
Project IDNIH-11089313 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with a history of diabetes who are at risk for or experiencing diabetic retinopathy.

Less likely to help

Patients without diabetes or those who do not have diabetic retinopathy may not benefit from this research.

What this research studies

This research focuses on understanding the mechanisms behind retinal neovascularization (RNV), a serious complication of diabetic retinopathy that can lead to blindness. The study aims to explore how endothelial cells change their metabolism to support the growth of new blood vessels in the retina, particularly in the context of long-term diabetes. By examining the Warburg effect, a metabolic shift that occurs in various diseases, the researchers hope to uncover new insights into how these changes contribute to vision loss. Patients may benefit from this research as it could lead to improved treatments for diabetic retinopathy.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies that prevent or treat vision loss in patients with diabetic retinopathy.

How similar studies have gone: Previous research has shown that metabolic changes in cells play a significant role in various diseases, suggesting that this approach may yield valuable insights into diabetic retinopathy.

Where this research is happening

  • Wayne State University
    Detroit, United States
    Active

Researchers

  • Principal investigator: Ibrahim, Ahmed S — Wayne State University
  • Study coordinator: Ibrahim, Ahmed S

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.